HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice.

AbstractBACKGROUND:
Aurintricarboxylic acid (ATA) and ethacrynic acid (ECA) have been reported to exhibit antiviral activity against vaccinia virus infections in cell culture by inhibiting early and late gene transcription, respectively. The purpose of this work was to determine if these inhibitors would effectively treat vaccinia virus infections in mice, which has not previously been studied.
METHODS:
ECA was investigated by cell culture plaque reduction assay for the inhibition of cowpox and vaccinia virus infections to clarify issues regarding its potency and selectivity. Mice infected intranasally with vaccinia virus were treated by intraperitoneal route twice daily for 5 days with ATA (10 and 30 mg/kg/day) and ECA (15 and 30 mg/kg/day) or once daily for 2 days with cidofovir (100 mg/kg/day).
RESULTS:
ECA caused 50% inhibition of virus plaque formation at 20-79 muM in four cultured cell lines, with 50% cytotoxicity at 84-173 muM, giving low (1.3-4.2) selectivity index values. Preliminary toxicity tests in uninfected mice indicated that ATA and ECA were both overtly toxic at 100 mg/kg/day. No protection from mortality was afforded by treatment of vaccinia virus infections with ATA or ECA, but 100% survival was achieved in the cidofovir group. ATA- and ECA-treated mice died significantly sooner than placebo-treated animals, indicating that these compounds exacerbated the infection.
CONCLUSIONS:
Both ATA and ECA lack antiviral potency and selectivity in cell culture. The compounds were ineffective in treating mice at intraperitoneal doses of <or=30 mg/kg/day. These compounds do not appear to have potential for the treatment of poxvirus infections in vivo.
AuthorsDonald F Smee, Brett L Hurst, Min-Hui Wong
JournalAntiviral chemistry & chemotherapy (Antivir Chem Chemother) Vol. 20 Issue 5 Pg. 201-5 (Apr 14 2010) ISSN: 2040-2066 [Electronic] England
PMID20413827 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antiviral Agents
  • Organophosphonates
  • Aurintricarboxylic Acid
  • Cytosine
  • Cidofovir
  • Ethacrynic Acid
Topics
  • Animals
  • Antiviral Agents (pharmacology, therapeutic use)
  • Aurintricarboxylic Acid (pharmacology, therapeutic use)
  • Cell Line
  • Cidofovir
  • Cytosine (analogs & derivatives, pharmacology)
  • Ethacrynic Acid (pharmacology, therapeutic use)
  • Mice
  • Mice, Inbred BALB C
  • Organophosphonates (pharmacology)
  • Respiratory Tract Infections (drug therapy, virology)
  • Time Factors
  • Vaccinia (drug therapy)
  • Vaccinia virus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: